Literature DB >> 23996013

Changes in bacterial glycolipids as an index of intestinal lactobacilli and epithelial glycolipids in the digestive tracts of mice after administration of penicillin and streptomycin.

Masao Iwamori1, Yuriko Iwamori, Shigeki Adachi, Taisei Nomura.   

Abstract

The major lipid constituent of symbiotic gram-positive bacteria in animals are phosphatidylglycerol, cardiolipin and dihexaosyl diglycerides (DH-DG), whose hydrophobic structures are characteristic of the environments, and the carbohydrate structures of DH-DGs are bacterial species-characteristic. Immunization of rabbits with intestinal lactobacilli generated antibodies against DH-DGs and their modified structures, among which Galα1-6-substituted DH-DG, i.e., Lactobacillus tetrahexaosyl diglyceride (LacTetH-DG), reacted with antibodies more intensely than DH-DG. Whereas, from the 16S-rRNA sequence, the intestinal lactobacilli in murine digestive tracts were revealed to be L. johnsonii, in which LacTetH-DG is present at the concentration of 2.2 ng per 1 × 10(6) cells. To obtain more accurate estimates of intestinal lactobacilli in several regions of the digestive tract of mice, LacTetH-DG was detected by TLC-immunostaining with anti-Lactobacillus antisera, being found in the stomach, cecum and colon of normal breeding mice, 1.0 × 10(9), 3.5 × 10(9) and 7.4 × 10(9) cells, respectively. Administration of penicillin and streptomycin for 6 days resulted in a reduction in the number of intestinal lactobacilli, the levels being 0 %, 30 % and 4 % of the control ones in the stomach, cecum and colon, respectively, which was associated with the accumulation of the contents in the tracts from the stomach to the cecum and with diarrhea. In addition, a reduced amount of fucosyl GA1 (FGA1) and a compensatory increase in GA1 due to the reduced activity of α1,2-fucosyltransferase in the small intestine and the enhanced discharge of FGA1 into the contents occurred in mice, probably due to the altered population of bacteria caused by administration of penicillin and streptomycin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996013     DOI: 10.1007/s10719-013-9494-6

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  21 in total

1.  Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.

Authors:  Lynne V McFarland
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

Review 2.  Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

Authors:  F Cremonini; S Di Caro; E C Nista; F Bartolozzi; G Capelli; G Gasbarrini; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

3.  Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota.

Authors:  Shigemitsu Tanaka; Takako Kobayashi; Prapa Songjinda; Atsushi Tateyama; Mina Tsubouchi; Chikako Kiyohara; Taro Shirakawa; Kenji Sonomoto; Jiro Nakayama
Journal:  FEMS Immunol Med Microbiol       Date:  2009-04-06

4.  A model of host-microbial interactions in an open mammalian ecosystem.

Authors:  L Bry; P G Falk; T Midtvedt; J I Gordon
Journal:  Science       Date:  1996-09-06       Impact factor: 47.728

5.  Characterization of three members of murine alpha1,2-fucosyltransferases: change in the expression of the Se gene in the intestine of mice after administration of microbes.

Authors:  B Lin; M Saito; Y Sakakibara; Y Hayashi; M Yanagisawa; M Iwamori
Journal:  Arch Biochem Biophys       Date:  2001-04-15       Impact factor: 4.013

6.  Involvement of the C-terminal tail of Arthrobacter ureafaciens sialidase isoenzyme M in cleavage of the internal sialic acid of ganglioside GM1.

Authors:  Masao Iwamori; Takeo Kaido; Yuriko Iwamori; Yasuhiro Ohta; Kentaro Tsukamoto; Shunji Kozaki
Journal:  J Biochem       Date:  2005-09       Impact factor: 3.387

7.  Bacterial species-characteristic profiles of molecular species, and the antigenicity of phospholipids and glycolipids in symbiotic Lactobacillus, Staphylococcus and Streptococcus species.

Authors:  Masao Iwamori; Masanori Nakasa; Kentaro Yamazaki; Yuriko Iwamori; Kyoko Tanaka; Daisuke Aoki; Shigeki Adachi; Taisei Nomura
Journal:  Glycoconj J       Date:  2012-05-26       Impact factor: 2.916

8.  Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials.

Authors:  Bradley C Johnston; Alison L Supina; Sunita Vohra
Journal:  CMAJ       Date:  2006-08-15       Impact factor: 8.262

9.  Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system.

Authors:  Y Umesaki; H Setoyama; S Matsumoto; A Imaoka; K Itoh
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

10.  Characterization of novel glycolipid antigens with an α-galactose epitope in lactobacilli detected with rabbit anti-Lactobacillus antisera and occurrence of antibodies against them in human sera.

Authors:  Masao Iwamori; Akihiro Sakai; Norihito Minamimoto; Yuriko Iwamori; Kyoko Tanaka; Daisuke Aoki; Shigeki Adachi; Taisei Nomura
Journal:  J Biochem       Date:  2011-07-22       Impact factor: 3.387

View more
  3 in total

1.  Enhanced fucosylation of GA1 in the digestive tracts of X-ray-irradiated mice.

Authors:  Masao Iwamori; Kyoko Tanaka; Shigeki Adachi; Daisuke Aoki; Taisei Nomura
Journal:  Glycoconj J       Date:  2016-11-18       Impact factor: 2.916

2.  Structural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel disease.

Authors:  Sabina Górska; Corine Sandstrőm; Justyna Wojas-Turek; Joanna Rossowska; Elżbieta Pajtasz-Piasecka; Ewa Brzozowska; Andrzej Gamian
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

3.  Lactobacillus johnsonii glycolipids, their structure and immunoreactivity with sera from inflammatory bowel disease patients.

Authors:  Mariola Paściak; Sabina Górska; Natalia Jawiarczyk; Andrzej Gamian
Journal:  Microb Biotechnol       Date:  2016-10-21       Impact factor: 5.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.